BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
Objective: Germline mutations in breast cancer susceptibility genes, breast cancer susceptibilitygene 1 (BRCA1) and breast cancer susceptibility gene1 (BRCA2) are responsiblefor a substantial proportion of high-risk breast and breast/ovarian cancer in families.Therefore, the aim of this study was to...
| Published in: | Cell Journal |
|---|---|
| Main Authors: | Fatemeh Keshavarzi, Gholam Reza Javadi, Nahid Nafissi, Mohammad Esmail Akbari, Vahid Reza Yassaee, Maryam Sharafi Farzad, Sirous Zeinali |
| Format: | Article |
| Language: | English |
| Published: |
Royan Institute (ACECR), Tehran
2010-01-01
|
| Subjects: | |
| Online Access: | http://www.celljournal.org/library/upload/article/af_48324723Keshavarzi.pdf |
Similar Items
Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01)
by: F Keshavarzi, et al.
Published: (2011-06-01)
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)
by: Yomali Ferreyra, et al.
Published: (2023-08-01)
Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland
by: Andrzej Jasiewicz, et al.
Published: (2022-04-01)
by: Andrzej Jasiewicz, et al.
Published: (2022-04-01)
Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)
by: Pankaja Umarane, et al.
Published: (2023-03-01)
Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
by: V.F. Esteves, et al.
Published: (2009-05-01)
by: V.F. Esteves, et al.
Published: (2009-05-01)
Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01)
by: Ashour M, et al.
Published: (2019-07-01)
Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System
by: Caroline de Oliveira Ferreira, et al.
Published: (2024-04-01)
by: Caroline de Oliveira Ferreira, et al.
Published: (2024-04-01)
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
by: Osman K., et al.
Published: (2022-12-01)
by: Osman K., et al.
Published: (2022-12-01)
A systematic review on the association between ovarian and prostate cancer with <I>BRCA1</I> and <I>BRCA2</I> gene
by: Sarpparajan Chitra Veena, et al.
Published: (2023-01-01)
by: Sarpparajan Chitra Veena, et al.
Published: (2023-01-01)
Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high‐risk breast cancer
by: Xiaozhen Wang, et al.
Published: (2019-06-01)
by: Xiaozhen Wang, et al.
Published: (2019-06-01)
A study of The Frequency and Type of Mutation in Exon 11 in BRCA1 and BRCA2 Genes In Breast Cancer Women With Positive Family History
by: Noor Jassim M, et al.
Published: (2018-06-01)
by: Noor Jassim M, et al.
Published: (2018-06-01)
A study of The Frequency and Type of Mutation in Exon 11 in BRCA1 and BRCA2 Genes In Breast Cancer Women With Positive Family History
by: Noor Jassim M, et al.
Published: (2018-06-01)
by: Noor Jassim M, et al.
Published: (2018-06-01)
BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
by: Hossein Neamatzadeh, et al.
Published: (2015-01-01)
by: Hossein Neamatzadeh, et al.
Published: (2015-01-01)
BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)
by: V. N. Dmitriev, et al.
Published: (2014-07-01)
Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
by: Anna Sokolenko, et al.
Published: (2025-06-01)
by: Anna Sokolenko, et al.
Published: (2025-06-01)
Different Mechanisms in Doxorubicin-Induced Cardiomyopathy: Impact of BRCA1 and BRCA2 Mutations
by: Hien C. Nguyen, et al.
Published: (2024-01-01)
by: Hien C. Nguyen, et al.
Published: (2024-01-01)
Study of the Carrier State for Five BRCA1/BRCA2 Deleterious Mutations in Bulgarian Women with Breast Cancer
by: Katia Kovacheva, et al.
Published: (2013-12-01)
by: Katia Kovacheva, et al.
Published: (2013-12-01)
Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
by: Lisa Krassuski, et al.
Published: (2019-08-01)
by: Lisa Krassuski, et al.
Published: (2019-08-01)
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
by: Dorra Ben Ayed-Guerfali, et al.
Published: (2021-03-01)
by: Dorra Ben Ayed-Guerfali, et al.
Published: (2021-03-01)
Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)
by: A. V. Bykova, et al.
Published: (2014-07-01)
Druggable Molecular Networks in <i>BRCA1/BRCA2</i>-Mutated Breast Cancer
by: Francesca Pia Carbone, et al.
Published: (2025-03-01)
by: Francesca Pia Carbone, et al.
Published: (2025-03-01)
Association Between Germline BRCA1/2 Gene Variants and Clinicopathological Features of Ovarian Cancer
by: Luo Y, et al.
Published: (2024-01-01)
by: Luo Y, et al.
Published: (2024-01-01)
Ovarian carcinoma in patients with BRCA mutation - a correlation between the growing pattern of peritoneal implants evaluated by CT/MRI and the genotype BRCA1 and BRCA2
by: Ana Catarina Vieira, et al.
Published: (2020-04-01)
by: Ana Catarina Vieira, et al.
Published: (2020-04-01)
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
by: Avantika Lal, et al.
Published: (2019-06-01)
by: Avantika Lal, et al.
Published: (2019-06-01)
Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 familiesResearch in context
by: Weang-Kee Ho, et al.
Published: (2024-03-01)
by: Weang-Kee Ho, et al.
Published: (2024-03-01)
Turkish population-based screening for first identified changes of BRCA1 and BRCA2 genes in breast and/or ovarian cancer patients
by: Tuğba Semerci Sevimli, et al.
Published: (2024-04-01)
by: Tuğba Semerci Sevimli, et al.
Published: (2024-04-01)
The role of BRCA1/2 in hereditary and familial breast and ovarian cancers
by: Yousef M. Hawsawi, et al.
Published: (2019-09-01)
by: Yousef M. Hawsawi, et al.
Published: (2019-09-01)
MANAGEMENT OF BREAST CANCER WITH BRCA GENE MUTATION
by: I Wayan Ari Sumardika, et al.
Published: (2013-09-01)
by: I Wayan Ari Sumardika, et al.
Published: (2013-09-01)
Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays
by: Fatemeh Sadeghi, et al.
Published: (2020-10-01)
by: Fatemeh Sadeghi, et al.
Published: (2020-10-01)
Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
by: Noor Muhammad, et al.
Published: (2023-11-01)
by: Noor Muhammad, et al.
Published: (2023-11-01)
Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia
by: Carolina Cortés, et al.
Published: (2019-07-01)
by: Carolina Cortés, et al.
Published: (2019-07-01)
Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)
by: McKinley Joanne M, et al.
Published: (2007-09-01)
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations
by: Steven A. Narod, et al.
Published: (2024-05-01)
by: Steven A. Narod, et al.
Published: (2024-05-01)
Age and Geographical Distribution in Families with <it>BRCA1/BRCA2 </it>Mutations in the Slovak Republic
by: Ciernikova Sona, et al.
Published: (2006-12-01)
by: Ciernikova Sona, et al.
Published: (2006-12-01)
Features and complexity of treatment of <i>BRCA</i>-associated ovarian cancer, chronic disease: literature review
by: T. V. Gorodnova, et al.
Published: (2024-11-01)
by: T. V. Gorodnova, et al.
Published: (2024-11-01)
BRCA 1/2 mutations and risk of uterine cancer: a systematic review and meta-analysis
by: Faezeh Zakerinasab, et al.
Published: (2024-01-01)
by: Faezeh Zakerinasab, et al.
Published: (2024-01-01)
The known genetic variants of BRCA1, BRCA2 and NOD2 in pancreatitis and pancreatic cancer risk assessment
by: Jarosław Matykiewicz, et al.
Published: (2025-01-01)
by: Jarosław Matykiewicz, et al.
Published: (2025-01-01)
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
by: Miyuki Kitahara, et al.
Published: (2021-11-01)
by: Miyuki Kitahara, et al.
Published: (2021-11-01)
Similar Items
-
Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer
by: F Keshavarzi, et al.
Published: (2011-06-01) -
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01) -
Frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients in South-East Poland
by: Andrzej Jasiewicz, et al.
Published: (2022-04-01) -
Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01) -
Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
by: V.F. Esteves, et al.
Published: (2009-05-01)
